SOURCE: Xtalks

Xtalks Webinars

November 17, 2015 07:00 ET

Top News Stories You Might have Missed From Xtalks; Xtalks Provides Current Articles Daily in the Life Science Industry

TORONTO, ON--(Marketwired - November 17, 2015) - Check out all news stories here:
Subscribe to our weekly newsletter:

Boehringer Ingelheim Plans to Dial-Down R&D --
(Nov 16) Germany-based pharmaceutical developer Boehringer Ingelheim has plans to slash its R&D budget over the next five years, and focus on growing their collaborator base to fund new therapies in the pipeline.

Diabetic Patients Could Help Protect Kidneys By Consuming A Potassium-Rich Diet --
(Nov 16) New research suggests that consuming a diet high in potassium could help diabetic patients protect their kidney function.

Cholesterol-Lowering Vaccine May Be More Effective Treatment For High Levels Of LDL --
(Nov 13) Although approximately 73.5 million adults in the US have high levels of low-density lipoprotein -- so-called 'bad' cholesterol -- only one in three of those affected, have their cholesterol under control.

AstraZeneca's Lupus Drug Shows Promise In Mid-Stage Clinical Trial --
(Nov 13) AstraZeneca's experimental lupus drug, anifrolumab, showed positive results at reducing disease activity in a mid-stage clinical trial.

Common Ingredient in Sunscreen May Be An Effective Antibacterial Coating For Medical Devices --
(Nov 12) Zinc oxide -- an ingredient commonly found in sunscreens -- may be effective at preventing microbial growth on medical device implants including pacemakers and artificial hips..

Electrical Stimulation Of Wounds May Be Alternative To Antibiotics --
(Nov 12) Researchers from Washington State University have developed a novel form of electrical stimulation which may be an effective alternative to antibiotics when treating wounds.

FDA Issues Warning Letters to Direct-To-Consumer Genetic Test Manufacturers --
(Nov 11) The Food and Drug Administration (FDA) has sent warning letters to direct-to-consumer genetic testing companies -- including DNA4Life and Interleukin Genetics -- for selling the tests without the necessary agency approval.

AstraZeneca To Acquire ZS Pharma --
(Nov 11) The deal is set to close by the end of the year with AstraZeneca set to pay $90 per share of ZS Pharma stock to absorb the US-based pharmaceutical developer and their 200 employees.

Chemotherapy Patch Could improve Cancer Treatment --
(Nov 10) Teo Wilkening, a mechanical engineering study in the Division of Engineering and Applied Science at Caltech University, has developed the technology for chemotherapy drug delivery in the form of a patch.

Rehabilitation Video Game For Cognitive Impairment Launched By Intendu --
(Nov 10) Israel-based game developer, Intendu, has launched a rehabilitation video game -- called the Functional Brain Trainer -- to help people recover from cognitive impairment.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit

Contact Information